Summary
A group of 27 patients with panic disorder with or without agoraphobia were compared with 10 control subjects before stress exposure. No statistically significant differences between patients and controls were found for the cardiovascular parameters. Skin conductance level and skin conductance reaction were significantly higher in the patient group. They also showed higher self-ratings in behavioural symptoms associated with anxiety. There were statistically significant higher venous plasma levels of norepinephrine in patients than in controls, although the epinephrine levels were similar. The number of binding sites of α2 and the affinity of3H-yohimbine to the α2-receptors on intact thrombocytes was statistically significantly lower in patients compared to controls. Significant differences between the gender groups of patients and controls were found for electrodermal activity and epinephrine levels. These data add further evidence to an overshooting activation of the noradrenergic pathway in patients with panic disorder, possibly based on a dysregulation of α2-receptor
Similar content being viewed by others
References
Ackenheil M Fröhler M, Goldig G et al (1982) Catecholaminbestimmung in Blut und Liquor mit Hochdruckflüssigkeitschromatographie. Arzneimittelforschung/Drug Res 32:893
Albus M (1987) Psychiatric patients and their responses to experimental stress. Stress Medicine 3:233–238
Albus M (1990) Psychophysiologie von Angsterkrankungen. Nervenarzt 61:639–646
Albus M, Stahl S, Müller-Spahn F, et al (1986) Psychophysiological differentiation of two types of anxiety and its pharmacological modification by minor transquilizer and beta-receptor-blocker. Biol Psychol 23:39–51
Albus M, Zahn TP, Breier A (1992) Anxiogenic properties of yohimbine. I. Behavioural, physiological and biochemical measures. Eur Arch Psychiatry Neurol Sci 241:337–344
American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders (DSM-III-R) 3 rd edn., revised. American Psychiatric Association, Washington DC
Andrade R, Aghajanian GK (1984) Single cell activity in the noradrenergic A-5 region: Responses to drugs and peripheral manipulations of blood pressure. Brain Res 242:125–135
Ballenger JC, Peterson GA, Laraia M, et al (1984) A study of plasma catecholamines in agoraphobia and the relationship of serum tricyclic levels to treatment response. In: Ballenger JC (ed) Biology of agoraphobia. American Psychiatric Press, Washington D.C.
Bond AJ, James DC, Lader MH (1974) Physiological and psychological measures in anxious patients. Psychol Med 4:364–373
Bondy B, Ackenheil M, Albus M, et al (1988) Adrenoceptor sensitivity in blood cells of anxiety patients: a predictor for stress response? In: Usdin E, Kopin IJ, Barchas J (eds) Progress in catecholamine research. Part C: clinical aspects, Alan R Liss, New York, pp 393–397
Brodde O, Daul A, O'Hara D (1984) β-Adrenoceptor changes in human lymphocytes, induced by dynamic exercise. Arch Pharmacol 325:190–192
Cameron OG, Smith CB, Hollingworth PJ et al (1984) Platelet alpha-2-adrenergic receptor binding and plasma catecholamines before and during imipramine treatment in patients with panic anxiety. Arch Gen Psychiatry 41:1144–1148
Cameron OG, Smith CB, Lee MA, et al (1990) Adrenergic status in anxiety disorders: Platelet alpha2-adrenergic receptor binding, blood pressure, pulse and plasma catecholamines in panic and generalized anxiety disorder patients and in normal subjects. Biol Psychiatry 28:3–20
Cedarbaum JM, Aghajanian GK (1977) Catecholamine receptor on locus coeruleus neurons. Eur J Pharmacol 44:375–385
Charney DS, Heninger GR, Breier A (1984) Noradrenergic function in panic anxiety: effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder. Arch Gen Psychiatry 41:751–763
Charney DS, Heninger GR (1986) Abnormal regulation of noradrenergic function in panic disorder. Arch Gen Psychiatry 43: 1042–1054
Charney DS, Woods SW, Goodman WK et al (1987) Neurobiological mechanisms of panic anxiety: biochemical and behavioural correlates of yohimbine-induced panic attacks. Am J Psychiatry 144(8):1030–1036
Charney DS, Woods SW, Krystall JH, et al (1992) Noradrenergic neuronal dysregulation in panic disorders: the effects of intravenous yohimbine and clonidine in panic disorder patients. Acta Psychiatr Scand 86:273–282
Cowley DS, Hyde TS, Dager SR, et al (1987) Lactate infusions: the role of baseline anxiety. Psychiatry Res 21:169–179
Daiguji M, Meltzer HY, U'Pritchard DC (1981) Human platelet alpha-2-adrenergic receptors: labeling with 3-H-yohimbine, a selective antagonist ligand. Life Sci 28:2705–2717
Erdmann G, Janke W, Bisping R (1984) Wirkungen und Vergleich der Wirkungen von vier experimentellen Belastungsreaktionen. Z Exp Angew Psychol 4:521–543
Fahrenberg J, Walschburger P, Förster F, et al (1979) Psychophysiologische Aktivierungsforschung. Ein Beitrag zu den Grundlagen der multivarianten Emotions- und Stresstheorie. Minerva Verlag, München
Frankenhäuser M, Dunne E, Lundberg U (1976) Sex differences in sympathetic-adrenal medullary reactions induced by different stressors. Psychopharmacology 47:1–5
freedman RR, Ianni P, Ettedgui E, et al (1984) Psychophysiological factors in panic disorder. Psychopathology 17(1):66–73
Fröhler M, Saito Y, Ackenheil M, et al (1985) Catecholaminergic binding sites on blood cells of healthy volunteers with special respect to circadian rhythms. Pharmacopsychiatry 1:147–148
Fröhler M, Saito Y, Ackenheil M, et al (1986) Circadian rhythm of catecholaminergic binding sites on blood cells of healthy volunteers. Psychiatry Psychobiol 1(4):309–316
Gaffney A, Fenton B, Lane L, et al (1988) Hemodynamics, ventilatory and biochemical responses of panic patients and normal controls with sodium lactate infusions and spontaneous panic attacks. Arch Gen Psychiatry 45:53–60
Gasic S, Grünberger J, Korn A, et al (1985) Biochemical, physical and psychological findings in patients suffering from cardiac neurosis. Neuropsychobiology 13:12–16
Hart JD (1974) Physiological responses of anxious and normal subjects to simple signal and non-signal auditory stimuli. Psychophysiology 11:443–451
Huang YH, Redmond DE, Snyder DR, Maas JW (1976) Loss of fear following bilateral lesions of the locus coeruleus in the monkey. Neurosci Abst 2:573–577
Johansson G (1972) Sex differences in the catecholamine output of children. Acta Physiol Scand 85:569–572
Johansson G, Post B (1974) Catecholamine output of males and females over a one-year period. Acta Physiol Scand 92:557–565
Kralik PM, Ho BT, Mathew RJ, et al (1982) Effects of adrenaline administration on platelet MAO of anxious and normal subjects. Neuropsychobiology 8:205–209
Lacey JI (1967) Somatic response patterning and stress: some revisions of activation theory. In: Appley MH, Trumbull R (eds) Psychological Stress. Appleton Century Croft, New York, pp 14–37
Lader MH, Wing L (1966) Physiological measures, sedative drugs, and morbid anxiety. Oxford University Press, London
Mason JW, Maher JT, Hartley LH, et al (1976) Selectivity of corticosteroids and catecholamine responses to various natural stimuli. In Serban G (ed) Psychopathology of human adaptation. Plenum Press, New York
Mathew RJ, Ho BT, Kralik PM, et al (1981) Catecholamines and monoamine oxidase activity in anxiety. Acta Psychiatr Scand 63(3):245–252
Moore RY, Bloom FE (1979) Central catecholamine systems: Anatomy and physiology of the norepinephrine and the epinephrine system. Annu Rev Neurosci 2:113–168
Motulsky HJ, Shattil SJ, Insel PA (1980) Characterization of adrenergic receptors on human platelets using 3-H-yohimbin. Biochem Biophys Res Commun 97:1562–1570
Nashold BS, Wilson WP, Slaughter G (1974) The mibdrain and pain. Adv Neurol 4:191–196
Nassif S, Kempf E, Cardo B, Velley L (1983) Neurochemical lesion of the locus coeruleus of the rat does not suppress the sedative effect of clonidine. Eur J Pharmacol 91:69–76
Nesse RM, Cameron OG, Curtis GC, et al (1984) Adrenergic function in patients with panic anxiety. Arch Gen Psychiatry 41: 771–776
Nesse RM, Curtis GC, Thyer BA, et al (1985) Endocrine and cardiovascular responses during phobic anxiety. Psychosom Med 47:320–332
Norman TR, Moises NM, Waterhouse BD, et al (1987) Platelet3H-rauwolfscine binding in patients with panic attacks. Psychiatry Res 22:43–48
Papp LA, Martinez J, Gorman JM (1988) Letter: arterial epinephrine levels in panic disorders. Psychiatry Res 25:111–112
Perry BD, U'Pritchard DC (1984) Alpha-adrenergic receptors in neural tissues: methods and applications of radioligand binding assays. In Marangos PJ, Campbell IC, Cohen RM (eds) Brain receptor methodologies. Academic Press, New York, pp 255–283
Rachman S, Lopatka C Levitt K (1988) Experimental analysis of panic-II: panic patients. Behav Res Ther 26(1):33–40
Redmond DE, Huang YH Snyder DR, Maas JW, Baulu J (1976) Behavioural changes following lesions of the locus coeruleus in Macaca arctoides. Neurosci Abst 1:472–479
Robinson JW, Whitsett SF, Kaplan BJ (1987) The stability of physiological reactivity over multiple sessions. Biol Psychol 24:129–139
Rosenthal HE (1967) A graphic method for the determination and presentation of binding parameters in a complex system. J Anal Biochem 20:525–532
Roth WT, Telch MJ, Taylor CB, et al (1986) Autonomic characteristics of agoraphobia with panic attacks. Biol Psychiatry 21: 1133–1154
Sanderson WC, Rapee RM, Barlow DH (1989) The influence of an illusion of control on panic attacks induced via inhalation of 5.5% carbon dioxide-enriched air. Arch Gen Psychiatry 46: 157–162
Scatchard G (1949) The attraction of proteins for small molecules and ions. Annu Rev NY Acad Sci 51: 590–672
Sibley DR, Lefkowitz RJ (1985) Molecular mechanisms of receptor desensitization using the β-adrenergic receptor-coupled adenylate cyclase system as a model. Nature 317:124–129
Toews ML, Waldo GL, Harden, et al (1984) Relationship between an altered membrane form and a low affinity from of the β-adrenergic receptor occurring during catecholamine-induced desensitization. Biol Chem 259(19):11844–11850
Uhde TW, Boulenger JP, Roy-Byrne PP et al (1985) Longitudinal course of panic disorder: clinical and biological considerations. Prog Neuropsychopharmacol Biol Psychiatry 9:39–51
Uhde TW, Stein MB, Siever LJ, et al (1989) Behavioural and physiological effects of short-term and long-term administration of clonidine in panic disorders. Arch Gen Psychiatry 46:170–177
van der Molen P, van den Hout MA, Vromen J, et al (1987) Cognitive determinants of lactate-induced anxiety. Behav Res Ther 24:677–680
Villacres EC, Hollifield M, Katon WJ, et al (1987) Sympathetic nervous system activity in panic disorder. Psychiatry Res 21: 313–321
Waldo GL, Northup JK, Perkins JP, et al (1983) Characterization of an altered membrane form of the β-adrenergic receptor produced during agonist-induced desensitization Biol Chem 258(22):13900–13908
Woods SW, Charney DS, Goodman WK, et al (1988) Carbon dioxide-induced anxiety. Arch Gen Psychiatry 4:43–52
Wyatt RJ, Portnoy B, Kupfer DJ, et al (1971) Resting catecholamine concentrations in patients with depression and anxiety. Arch Gen Psychiatry 24:65–70
Yeragani V, Balon R, Pohl R (1989) Lactate infusions in panic disorder patients and normal controls: autonomic measures and subjective anxiety. Acta Psychiatr Scand 79:32–40
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Braune, S., Albus, M., Fröhler, M. et al. Psychophysiological and biochemical changes in patients with panic attacks in a defined situational arousal. Eur Arch Psychiatry Clin Nuerosci 244, 86–92 (1994). https://doi.org/10.1007/BF02193524
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02193524